DDVRX
Price
$13.71
Change
+$0.13 (+0.96%)
Updated
Jun 26 closing price
Net Assets
2.17B
RMEBX
Price
$58.60
Change
+$0.43 (+0.74%)
Updated
Jun 26 closing price
Net Assets
106.24B
Interact to see
Advertisement

DDVRX vs RMEBX

Header iconDDVRX vs RMEBX Comparison
Open Charts DDVRX vs RMEBXBanner chart's image
Macquarie Value R
Price$13.71
Change+$0.13 (+0.96%)
VolumeN/A
Net Assets2.17B
American Funds American Mutual R2E
Price$58.60
Change+$0.43 (+0.74%)
VolumeN/A
Net Assets106.24B
DDVRX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DDVRX vs. RMEBX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDVRX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 106B vs. DDVRX (2.17B). DDVRX pays higher dividends than RMEBX: DDVRX (1.25) vs RMEBX (1.16). DDVRX was incepted earlier than RMEBX: DDVRX (20 years) vs RMEBX (11 years). DDVRX (1.22) is less costly to investors than RMEBX (1.07). DDVRX (31.00) and RMEBX (31.00) have comparable annual turnover. DDVRX has a lower initial minimum investment than RMEBX: DDVRX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 9.50 vs. DDVRX (-19.06). RMEBX return over 5 years is better than : 62.71 vs. DDVRX (-21.35).
DDVRXRMEBXDDVRX / RMEBX
Total Expense Ratio1.221.07114%
Annual Report Gross Expense Ratio1.221.07114%
Fund Existence20 years11 years-
Gain YTD1.1097.31515%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.17B106B2%
Annual Yield % from dividends1.251.16108%
Returns for 1 year-19.069.50-201%
Returns for 3 years-26.6825.88-103%
Returns for 5 years-21.3562.71-34%
Returns for 10 years-17.9274.51-24%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR5.310.12
+2.31%
Vir Biotechnology
SPRO2.90N/A
N/A
Spero Therapeutics
AMED98.03-0.05
-0.05%
Amedisys
SHG44.16-0.24
-0.54%
Shinhan Financial Group Co Ltd
DFDV17.94-0.92
-4.88%
DeFi Development Corp